Bipolar Disorder


Amber Light Therapy for Bipolar Disorder

What bipolar patients, as well as their doctors, may not know is the amount of current research centered on light-dark therapy and the potential implications of this research on treating bipolar.

Pediatric Bipolar Disorder (PBD): A Skeptical, Mainstream, Non-US Perspective

Although practicing in Australia, I have followed the PBD phenomenon in the USA for several years. PBD had become the most common diagnosis in pre-pubertal children in US psychiatric inpatient units by 2004.

How We Got Here: The Psychodynamics of Juvenile Bipolar Disorder and the Clinician

The studies have been done and the consensus is in. Juvenile bipolar disorder (JBD) has probably been overdiagnosed recently, and the DSM-5 will describe a narrower phenotype to qualify for the diagnosis. At this point, it is worth thinking about how we got here, and what it means for clinicians as a cautionary tale for the future.

Research Update

Early Intervention for Youth at Risk for Bipolar Disorder

Bipolar I and II disorder (BD I and II) together affect an estimated 2.5% of US adolescents (Merikangas KR et al, Arch Gen Psychiatry 2012; 68(3):241–251), and there is little argument that they result in significant morbidity.

Free Article

Pharmacologic Treatment of Youth with Bipolar Disorder: Where to Next? [Free Article]

Bipolar Disorder
The Carlat Child Psychiatry Report (CCPR), Bipolar Disorder, December 2012

Bipolar disorder presents unique pharmacologic challenges. Those treating children or adolescents with bipolar disorder face the additional challenge of having far less information to inform their treatment decisions.